Authors: FAIVRE S RAYMOND E RIXE O GOLDWASSER F MANGOLD GL VONHOFF DD JUNIEWICZ P CVITKOVIC E

Citation: S. Faivre et al., PRECLINICAL SYNERGY OF OXALIPLATIN IN COMBINATION WITH OTHER ANTITUMOR AGENTS, Annals of oncology, 9, 1998, pp. 627-627

Authors: FAIVRE S RAYMOND E RIXE O GOLDWASSER F MANGOLD GL VONHOFF DD JUNIEWICZ P CVITKOVIC E

Citation: S. Faivre et al., IN-VITRO AND IN-VIVO RATIONATE FOR OXALIPLATIN IN COMBINATION WITH OTHER ANTITUMOR AGENTS, Annals of oncology, 9, 1998, pp. 554-554

Authors: FAIVRE S RAYMOND E CVITKOVIC E JUNIEWICZ P WOYNAROWSKI JM

Citation: S. Faivre et al., IN-VITRO RATIONATE FOR GEMCITABINE (DFDC)-OXALIPLATIN (L-OHP) COMBINATIONS IN GASTROINTESTINAL TUMORS, Annals of oncology, 9, 1998, pp. 561-561

Authors: WOYNAROWSKI JM CHAPMAN WG NAPIER C HERZIG MCS JUNIEWICZ P

Citation: Jm. Woynarowski et al., SEQUENCE-SPECIFICITY AND REGION-SPECIFICITY OF OXALIPLATIN ADDUCTS INNAKED AND CELLULAR DNA, Molecular pharmacology, 54(5), 1998, pp. 770-777

Authors: FALTYNEK CR WANG S MILLER D MAUVAIS P GAUVIN B REID J XIE W HOEKSTRA S JUNIEWICZ P SARUP J LEHR R SAWUTZ DG MURPHY D

Citation: Cr. Faltynek et al., INHIBITION OF T-LYMPHOCYTE ACTIVATION BY A NOVEL P56(LCK) TYROSINE KINASE INHIBITOR, Journal of enzyme inhibition, 9(2), 1995, pp. 111-122